Glucose transporters and glucose transport in skeletal muscles of 1- to 25-mo-old rats.
It is widely thought that aging results in development of insulin resistance in skeletal muscle. In this study, we examined the effects of growth and aging on the concentration of the GLUT-4 glucose transporter and on glucose transport activity in skeletal muscles of female Long-Evans rats. Relative amounts of immunoreactive GLUT-4 protein were measured in muscle homogenates of 1-, 10-, and 25-mo-old rats by immunoblotting with a polyclonal antibody directed against GLUT-4. In the epitrochlearis, plantaris, and the red and white regions of the quadriceps muscles, GLUT-4 immunoreactivity decreased by 14-33% between 1 and 10 mo of age and thereafter remained constant. In flexor digitorum brevis (FDB) and soleus muscles, GLUT-4 concentration was similar at all three ages studied. Glucose transport activity was assessed in epitrochlearis and FDB muscles by incubation with 2-deoxyglucose under the following conditions: basal, submaximal insulin, and either maximal insulin or maximal insulin combined with contractile activity. Glucose transport in the epitrochlearis muscle decreased by approximately 60% between 1 and 4 mo of age and then did not decline further between 4 and 25 mo of age. Transport activity in the FDB assessed with a maximally effective insulin concentration decreased only slightly (< 20%) between 1 and 7 mo of age. Aging, i.e., the transition from young adulthood to old age, was not associated with a decrease in glucose transport activity in either the epitrochlearis or the FDB.(ABSTRACT TRUNCATED AT 250 WORDS)
Gulve
E A
EA
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
Henriksen
E J
EJ
Rodnick
K J
KJ
Youn
J H
JH
Holloszy
J O
JO
D000375:Aging / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D003847:Deoxyglucose / Q000493:pharmacokinetics; D005260:Female; D005947:Glucose / Q000493:pharmacokinetics*; D051275:Glucose Transporter Type 4; D015151:Immunoblotting; D009004:Monosaccharide Transport Proteins / Q000378:metabolism / Q000502:physiology*; D009124:Muscle Proteins; D009132:Muscles / Q000378:metabolism / Q000502:physiology*; D051381:Rats
D051275:Glucose Transporter Type 4; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; C495694:Slc2a4 protein, rat; D003847:Deoxyglucose; D005947:Glucose